EPLBB09	Risk factors and prognoses for low-level HIV-1 viremia: a long-time observational study	E-poster	Viral load and CD4 monitoring
EPLBC01	Mapping and estimating the size of virtual key populations: potential approaches	E-poster	Surveillance of HIV in key populations
EPLBC02	Opioid-agonist therapy in Ukraine has a large potential for expansion and demonstrates significant reduction of risky injection practices and overdose among people who inject opioid drugs	E-poster	HIV prevention services for key populations
EPLBC03	Jitegemee (rely on yourself): acceptability and feasibility of a personal savings intervention to reduce HIV risk among female sex workers in Kisumu and Siaya Counties, Kenya	E-poster	HIV prevention services for key populations
EPLBC04	Transgender women (TGW) in HPTN 083: an evaluation of safety, efficacy, and gender affirming hormonal therapy (GAHT) interactions with long-acting cabotegravir (CAB-LA)	E-poster	Other new HIV prevention tools
EPLBC05	Phase 3B, randomized, open-label, safety study of dapivirine vaginal ring and oral emtricitabine 200mg/tenofovir disoproxil fumarate 300 mg tablet in breastfeeding mother-infant pairs	E-poster	Other new HIV prevention tools
EPLBC06	iSTAMP: Implementation of HIV self-testing among Black and Hispanic MSM recruited online in 11 States, 2020-2021	E-poster	HIV self-testing
EPLBC07	Number of pregnancies and its impact on adherence to ART during pregnancy in women living with HIV, followed up in 2020 in a specialized health center in São Paulo, Brazil	E-poster	Strategies to improve re-engagement
EPLBC08	Population trends in HIV service delivery, viral suppression, and incidence before and during the COVID-19 era in Rakai, Uganda	E-poster	Effects of the COVID-19 on HIV epidemiology and prevention
EPLBC09	Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia: a test negative design	E-poster	Epidemiology of COVID-19 among persons living with HIV and / or including tuberculosis